ESP-1336

N/A

Report date: 2025/07/04 11:37:23
NMEFirst In Class

Base Information

Drug NameESP-1336
Drug Alias NameESP-1336
ClassificationOther
Mechanisms of ActionATP-citrate synthase inhibitors
TargetsATP-citrate synthase
Therapy Area/IndicationsCholangitis, Sclerosing
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEsperion Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesEsperion Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsCholangitis, Sclerosing
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A